America can either cede the future of biotechnology to our adversaries or summon the vision and resolve to lead it.

The biotechnology market is entering a new growth phase, driven by the convergence of genomic science, artificial ...

Get key Q3 2025 insights on Vir Biotechnology’s accelerated hepatitis delta trial milestones, strong financials, and upcoming data catalysts.

Vir Biotechnology (VIR) delivered earnings and revenue surprises of -67.14% and -96.59%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

Vir Biotechnology, Inc. ( ($VIR) ) has released its Q3 earnings. Here is a breakdown of the information Vir Biotechnology, Inc. presented to its ...

A research team led by Professor Wang Peng from the Hefei Institutes of Physical Science of the Chinese Academy of Sciences, ...

iShares Biotechnology ETF (IBB) offers targeted exposure to the U.S. biotechnology sector, providing investors with access to a broad basket of industry-leading biotech equities. The fund's strategy ...

Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on changing the possible for patients through engineered cells, today announced that it will webcast its presentation at the TD Cowen ...

The apparel industry accounts for 10% of greenhouse gas emissions. Biotechs are working on reengineering natural products to make more sustainable textiles, which are gaining traction.

The Nation has won overall best at the Ninth Open Forum on Agricultural Biotechnology (OFAB) Nigeria Media Awards. The ...

When Ryan Brazil told her students, “We make space for each other,” she offered a truth that extends well beyond her ...

Nautilus Biotechnolgy ( ($NAUT) ) has shared an announcement. On November 3, 2025, Nautilus Biotechnology, Inc. announced that it has regained ...